RecruitingNCT04724603
Phage Safety Retrospective Cohort Study
Sponsor
Hospices Civils de Lyon
Enrollment
25 participants
Start Date
Feb 1, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
The aim of this study is to determine the imputability of adverse events in patients who have had phage therapy for the treatment of their bone or joint or implant infection, in order to find out whether these adverse effects are related to surgery, antibiotic treatment or bacteriophages.
Eligibility
Inclusion Criteria1
- patients having had a bone or joint or implant infection treated by phagotherapy and having had an adverse event
Exclusion Criteria1
- \-
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERpatients having had avderse event after phagotherapy for bone or joint or implant infection
to determine the accountability of adverse effects in having had avderse event after phagotherapy for bone or joint or implant infection
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04724603